These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 21982660)

  • 1. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
    Pauly DF; Johnson BD; Anderson RD; Handberg EM; Smith KM; Cooper-DeHoff RM; Sopko G; Sharaf BM; Kelsey SF; Merz CN; Pepine CJ
    Am Heart J; 2011 Oct; 162(4):678-84. PubMed ID: 21982660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study.
    Denardo SJ; Wen X; Handberg EM; Bairey Merz CN; Sopko GS; Cooper-Dehoff RM; Pepine CJ
    Clin Cardiol; 2011 Aug; 34(8):483-7. PubMed ID: 21780138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.
    Rambarat CA; Elgendy IY; Handberg EM; Bairey Merz CN; Wei J; Minissian MB; Nelson MD; Thomson LEJ; Berman DS; Shaw LJ; Cook-Wiens G; Pepine CJ
    Int J Cardiol; 2019 Feb; 276():8-13. PubMed ID: 30293664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
    Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
    J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
    Mehta PK; Goykhman P; Thomson LE; Shufelt C; Wei J; Yang Y; Gill E; Minissian M; Shaw LJ; Slomka PJ; Slivka M; Berman DS; Bairey Merz CN
    JACC Cardiovasc Imaging; 2011 May; 4(5):514-22. PubMed ID: 21565740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.
    Bavry AA; Handberg EM; Huo T; Lerman A; Quyyumi AA; Shufelt C; Sharaf B; Merz CN; Cooper-DeHoff RM; Sopko G; Pepine CJ
    Am Heart J; 2014 Jun; 167(6):826-32. PubMed ID: 24890531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
    Pepine CJ; Rouleau JL; Annis K; Ducharme A; Ma P; Lenis J; Davies R; Thadani U; Chaitman B; Haber HE; Freedman SB; Pressler ML; Pitt B;
    J Am Coll Cardiol; 2003 Dec; 42(12):2049-59. PubMed ID: 14680725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.
    Aldiwani H; Zaya M; Suppogu N; Quesada O; Johnson BD; Mehta PK; Shufelt C; Petersen J; Azarbal B; Samuels B; Anderson RD; Shaw LJ; Kar S; Handberg E; Kelsey SF; Pepine CJ; Bairey Merz CN
    J Am Heart Assoc; 2020 Feb; 9(4):e013168. PubMed ID: 32063125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
    Anderson RD; Petersen JW; Mehta PK; Wei J; Johnson BD; Handberg EM; Kar S; Samuels B; Azarbal B; Kothawade K; Kelsey SF; Sharaf B; Shaw LJ; Sopko G; Bairey Merz CN; Pepine CJ
    J Interv Cardiol; 2019; 2019():7169275. PubMed ID: 31772544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
    Bairey Merz CN; Handberg EM; Shufelt CL; Mehta PK; Minissian MB; Wei J; Thomson LE; Berman DS; Shaw LJ; Petersen JW; Brown GH; Anderson RD; Shuster JJ; Cook-Wiens G; Rogatko A; Pepine CJ
    Eur Heart J; 2016 May; 37(19):1504-13. PubMed ID: 26614823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
    Park K; Quesada O; Cook-Wiens G; Wei J; Minissian M; Handberg EM; Merz NB; Pepine CJ
    J Womens Health (Larchmt); 2020 Apr; 29(4):487-492. PubMed ID: 31859580
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.
    Mohandas R; Segal MS; Huo T; Handberg EM; Petersen JW; Johnson BD; Sopko G; Bairey Merz CN; Pepine CJ
    PLoS One; 2015; 10(5):e0125374. PubMed ID: 25951606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: A randomized placebo-controlled trial.
    Michelsen MM; Rask AB; Suhrs E; Raft KF; Høst N; Prescott E
    PLoS One; 2018; 13(6):e0196962. PubMed ID: 29883497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of coronary microvascular dysfunction.
    Bairey Merz CN; Pepine CJ; Shimokawa H; Berry C
    Cardiovasc Res; 2020 Mar; 116(4):856-870. PubMed ID: 32087007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease.
    Tagliamonte E; Rigo F; Cirillo T; Astarita C; Quaranta G; Marinelli U; Caruso A; Romano C; Capuano N
    Echocardiography; 2015 Mar; 32(3):516-21. PubMed ID: 25041234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).
    Mekonnen G; Hayek SS; Mehta PK; Li Q; Mahar E; Mou L; Kenkre TS; Petersen JW; Azarbal B; Samuels B; Anderson RD; Sedlak T; Zaya M; Agarwal M; Haftbaradaran A; Minissian M; Handberg E; Pepine CJ; Cogle CR; Bairey Merz CN; Waller EK; Quyyumi AA
    Atherosclerosis; 2016 Oct; 253():111-117. PubMed ID: 27596135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Nichols WW; Denardo SJ; Davidson JB; Huo T; Bairey Merz CN; Pepine CJ
    Am Heart J; 2015 Dec; 170(6):1243-54. PubMed ID: 26678647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Mohandas R; Sautina L; Li S; Wen X; Huo T; Handberg E; Chi YY; Merz CN; Pepine CJ; Segal MS
    PLoS One; 2013; 8(12):e81595. PubMed ID: 24312563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    Suppogu N; Wei J; Nelson MD; Cook-Wiens G; Cheng S; Shufelt CL; Thomson LEJ; Tamarappoo B; Berman DS; Samuels B; Azarbal B; Anderson RD; Petersen JW; Handberg EM; Pepine CJ; Merz CNB
    Int J Cardiol; 2020 Jun; 309():19-22. PubMed ID: 32037132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.
    Shah NR; Cheezum MK; Veeranna V; Horgan SJ; Taqueti VR; Murthy VL; Foster C; Hainer J; Daniels KM; Rivero J; Shah AM; Stone PH; Morrow DA; Steigner ML; Dorbala S; Blankstein R; Di Carli MF
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.